Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis

Laboratory Animal Science

Volumn 46, Issue 5, 1996, Pages 482-492

  Goverman, Joan ^a   Brabb, Thea ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN RECOGNITION; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE COURSE; GENETIC LINKAGE; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; REVIEW; STRAIN DIFFERENCE; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICE; MULTIPLE SCLEROSIS; RATS; RODENT DISEASES; RODENTIA;

EID: 0029851099     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Pasteur, L. 1885. Méthode pur prévenir la rage après morsure. Comptes rendus des séances de l'Académie des. Sciences 101:765-774.
2. Remlinger, P. 1904. Contribution à l'étude de la toxine rabique: faits cliniques. C. R. Soc. Biol. 56:349.
3. Stuart, G., and K. S. Krikorian. 1928. The neuro-paralytic accidents of anti-rabies treatment. Ann. Trop. Med. Parasitol. 22:327-377.
4. Rivers, T. M., and F. F. Schwentker. 1935. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61:689-701.
5. Rivers, T. M., D. H. Sprunt, and G. P. Berry. 1933. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58:39-53.
6. Martin, R., and H. F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 321:121-182.
7. Martin, R., H. F. McFarland, and D. E. McFarland. 1992. Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10:153-187.
8. Kurtzke, J. F. 1993. Epidemiological evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
9. Zamvil, S. S., and L. Steinman. 1988. The T lymphocyte in experimental allergic encephalomyelitis. Ann. Rev. Immunol. 8:579-621.
10. Bernard, C. C. A., and P. R. Carnegie. 1973. Experimental allergic encephalomyelitis in mice: immune response to mouse spinal cord and myelin basic protein. J. Immunol. 114:1537-1540.
11. Linthicum, D. S. 1982. Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease. Immunobiology 162:211-220.
12. Levine, S., and E. J. Wenk. 1965. A hyperacute form of allergic encephalomyelitis. Am. J. Pathol. 47:61-88.
13. Paterson, P. Y. 1960. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 111:119-135.
14. Poser, C., D. Paty, L. Scheinberg, et al. 1983. New diagnostic criteria for multiple sclerosis. Ann. Neurol. 13:227-231.
15. McFarlin, D. E., and H. F. McFarland. 1982. Multiple sclerosis. I. N. Engl. J. Med. 307:1183-1188.
16. McFarlin, D. E., and H. F. McFarland. 1982. Multiple sclerosis. II. N. Engl. J. Med. 307:1246-1251.
17. Lublin, F. D., P. H. Maurer, R. G. Berry, et al. 1981. Delayed relapsing experimental allergic encephalomyelitis in mice. J. Immunol. 126:819-822.
18. Tuohy, V. K., R. A. Sobel, and M. B. Lees. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J. Immunol. 140:1868-1873.
19. Van der Veen, R. C., J. L. Trotter, H. B. Clark, et al. 1989. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:183-191.
20. Mokhtarian, F., D. E. McFarlin, and C. S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309:356-358.
21. Fritz, R. B., L. L. Perry, and C. H. Chou. 1984. Genetic control of myelin basic protein-induced experimental allergic encephalomyelitis in mice. Prog. Clin. Biol. Res. 146:235-242.
22. Fritz, R. B., M. J. Skeen, C. H. Chou, et al. 1985. Major histocompatibility complex-linked control of murine immune response to myelin basic protein. J. Immunol. 134:2328-2332.
23. Swanberg, R. H. 1988. Experimental allergic encephalomyelitis. Methods Enzymol. 162:413-421.
24. Willenborg, D. O. 1979. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123:1145-1150.
25. Rose, L. M., T. Richards, and E. C. Alvord, Jr. 1994. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis. Lab. Anim. Sci. 44:508-512.
26. Lassmann, H. 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis, p. 76-78. Springer-Verlag, New York.
27. Sobel, R. A. 1995. The pathology of multiple sclerosis. Neurol. Clin. 13:1-21.
28. Lassmann, H., F. Zimprich, K. Rossler, et al. 1991. Inflammation in the nervous system: basic mechanisms and immunological concepts. Rev. Neurol. 147:76-81.
29. Hillert, J., and O. Ollerup. 1993. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype. Neurology 43:163-168.
30. Olsson, T. 1992. Immunology of MS. Curr. Opin. Neurol. Neurosurg. 5:195-202.
31. Abbas, A. K., A. H. Lichtman, and J. S. Pober. 1994. Cellular and molecular immunology, 2nd ed., p. 97-114. The W. B. Saunders Co., Philadelphia.
32. Jansson, L., T. Olsson, B. Hojeberg, et al. 1991. Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice. Eur. J. Immunol. 21:693-699.
33. Hashim, G., A. A. Vandenbark, D. P. Gold, et al. 1991. T-cell lines specific for an immunodominant epitope of human basic protein define an encephalitogenic determinant for experimental autoimmune encephalomyelitis-resistant Lou/M rats. J. Immunol. 146:515-520.
34. Bodmer, J. G., S. G. E. Marsh, P. Parham, et al. 1990. Nomenclature for factors of the HLA system. Hum. Immunol. 28:326-342.
35. Haegert, D. G., and G. S. Francis. 1992. Contribution of a single DQ-chain residue to multiple sclerosis in French Canadians. Hum. Immunol. 34:85-90.
36. Bertram, J., and E. Kuwert. 1982. HLA antigen frequencies in multiple sclerosis. Eur. J. Neurol. 7:74-79.
37. Marrosu, H. G., F. Muntoni, M. R. Murru, et al. 1988. Sardinian multiple sclerosis is associated with HLA-DR4: a serological and molecular analysis. Neurology 38:1749-1753.
38. Kurdi, A., I. Ayesh, A. Addallat, et al. 1977. Different B-lymphocyte alloantigens associated with multiple sclerosis in Arabs and northern Europeans. Lancet 1:1123-1125.
39. Gorodezky, C., R. Najera, B. E. Rangel, et al. 1986. Immunogenetic profile of multiple sclerosis in Mexicans. Hum. Immunol. 16:364-374.
40. Naito, S., Y. Kuroiwa, T. Itoyama, et al. 1978. HLA and Japanese MS. Tissue Antigens 12:19-24.
41. Fujimura, F. K. 1994. Diagnosis and the new genetics. Curr. Opin. Biotech. 5:654-662.
42. Ebers, G. C., D. E. Bukman, A. D. Sadovnick, et al. 1986. Population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315:1638-1642.
43. McFarland, H. F., J. L. Greenstein, D. E. McFarlin, et al. 1985. Family and twin studies in multiple sclerosis. Ann. N. Y. Acad. Sci. 436:118-124.
44. McFarland, H. F. 1992. Twin studies and multiple sclerosis. Ann. Neurol. 332:722-723.
45. Sadovnick, A. D., H. Armstrong, G. P. Rice, et al. 1993. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33:281-285.
46. Kabat, E. A., A. Wolf, and A. E. Bezer. 1947. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterozygous and homologous brain tissue with adjuvants. J. Exp. Med. 85:117-129.
47. Sobel, R. A., J. M. Greer, and V. K. Kuchroo. 1994. Minireview: autoimmune responses to myelin proteolipid protein. Neurochem. Res. 19:915-921.
48. Williams, K. A., and C. M. Deber. 1993. The structure and function of central nervous system myelin. Crit. Rev. Clin. Lab. Sci. 30:29-64.
49. Berger, C. T., L. Perry, et al. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364-1372.
50. Linington, C., M. Bradl, H. Lassmann, et al. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Neurology 33:19-23.
51. Warren, K. G., and I. Catz. 1990. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 96:19-27.
52. Sun, J. B. 1993. Autoreactive T and B cells in nervous system disease. Acta Neurol. Scand. 87(Suppl.):1-56.
53. Sun, J. B., T. Olsson, W. Z. Wang, et al. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1461-1468.
54. Fredrikson, S., J. Michelsberg, J. Hillert, et al. 1992. Conjugal multiple sclerosis: immunogenetic characterization and analysis of T- and B-cell reactivity to myelin proteins. Neurology 42:577-582.
55. Laterre, E. C., A. Collewaert, J. F. Heremans, et al. 1970. Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology 20:982-990.
56. Alvord, E. C., Jr., S. Hruby, C. M. Shaw, et al. 1984. Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases, p. 358-363. In E. C. Alvord, Jr., M. W. Kies, and A. J. Suckling (ed.), Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. Alan R. Liss, Inc., New York.
57. Lowenthal, A., M. Van Sande, and D. Karcher. 1960. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J. Neurochem. 6:51-56.
58. Olsson, T., W. Wei Zhi, B. Hojeberg, et al. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon γ. J. Clin. Invest. 86:981-985.
59. Valli, A., A. Sette, L. Kappos, et al. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616-628.
60. Chou, Y. K., D. N. Bourdette, G. Offner, et al. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:105-113.
61. Olsson, T., J. Sun, J. Hillert, et al. 1992. Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur. J. Immunol. 22:1083-1087.
62. Pelfrey, C., J. Trotter, L. Rhame, et al. 1993. Myelin proteolipid protein (PLP) peptide reactivity in multiple sclerosis (abstr.). J. Immunol. 150:174A.
63. + T cells from multiple sclerosis. J. Neuroimmunol. 46:33-42.
64. Trotter, J. L., W. F. Hickey, R. C. Van der Veen, et al. 1991. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J. Neuroimmunol. 33:55-62.
65. Ota, K., M. Matsui, E. L. Milford, et al. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187.
66. Zhang, J., R. Medaer, G. A. Hashim, et al. 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32:330-338.
67. Martin, R., R. Voskuhl, M. Fleralage, et al. 1993. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis. Ann. Neurol. 34:524-535.
68. Joshi, N., K. Usuku, and S. L. Hauser. 1993. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage. Ann. Neurol. 34:385-393.
69. Voskuhl, R. R., R. Martin, and H. F. McFarland. 1993. A functional basis for the association of HLA class II genes and susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family. J. Neuroimmunol. 42:199-208.
70. Allegretta, M., J. A. Nicklas, S. Sriam, et al. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721.
71. Satyanarayana, K., Y. K. Chou, D. Bourdette, et al. 1993. Epitope specificity and V gene expression of cerebrospinal fluid T cells specific for intact versus cryptic epitopes of myelin basic protein. J. Neuroimmunol. 44:57-67.
72. Kerlero de Rosb, N., R. Milo, and M. B. Lees. 1993. Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602-2608.
73. Sun, J., H. Link, T. Olsson, et al. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490-1495.
74. Linington, C., T. Berger, L. Perry, et al. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J, Immunol. 23:1364-1372.
75. Xiao, B. G., C. Linington, and H. Link. 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:91-96.
76. Link, H., J. B. Sun, Z. Wang, et al. 1992. Virus-specific and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:63-74.
77. Kronenberg, M., G. Siu, L. E. Hood, et al. 1986. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Ann. Rev. Immunol. 4:529-591.
78. Urban, J. L., S. J. Horvath, and L. Hood. 1989. Autoimmune T cells: immune recognition of normal and ariant peptide epitopes and peptide-based therapy. Cell 59:257-271.
79. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, et al. 1988. Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263-273.
80. Burns, F. R., X. Li, N. Shen, et al. 1989. Both rat and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:1586-1596.
81. Chluba, J., C. Steeg, A. Becker, et al. 1989. T-cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes. Eur. J. Immunol. 19:279-284.
82. Heber-Katz, E., and H. Acha-Orbea. 1989. The V-region disease hypothesis: evidence from autoimmuune encephalomyelitis. Immunol. Today 10:164-169.
83. Heber-Katz, E., and H. Acha-Orbea. 1990. The autoimmune T-cell receptor: epitopes, idiotopes and malatopes. Clin. Immunol. Immunopathol. 55:1-8.
84. Sakai, K., S. S. Zamvil, D. J. Mitchell, et al. 1988. Characterization of a major encephalitogenic T-cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19:21-32.
85. Sakai, K., A. A. Sinha, D. J. Mitchell, et al. 1988. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. USA 85:8608-8612.
86. Kuchroo, V. K., M. Collins, A. al-Sabbagh, et al. 1994. T-cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR Vβ8.2 transgenic (Tg) mice. J. Exp. Med. 179:1659-1664.
87. Lamont, A. G., A. Sette, R Fujinami, et al. 1990. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for las molecules. J. Immunol. 145:1687-1693.
88. Kuchroo, V. K., J. M. Greer, D. Kaul, et al. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by diverse T-cell repertoire. J. Immunol. 153:3326-3336.
89. Owhashi, M., and E. Heber-Katz. 1988. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T-cell receptors specific for myelin basic protein. J. Exp. Med. 168:2153-2164.
90. Zaller, D. M., G. Osman, O. Kanagawa, et al. 1990. Prevention and treatment of murine experimental allergic encephalomyelitis with T-cell receptor Vβ-specific antibodies. J. Exp. Med. 171:1943-1955.
91. Urban, J. L., V. Kumar, D. H. Kono, et al. 1988. Restricted use of the T-cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
92. Nicholson, L. B., J. M. Greer, R. A. Sobel, et al. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397-405.
93. Brocke, S., K. Gijbels, M. Allegretta, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343-346.
94. + cells in T-cell receptor peptide-induced clonal unresponsiveness. Science 259:91-94.
95. Critchfield, J. M., M. K. Racke, and J. C. Zuniga-Pflucker. 1994. T-cell deletion in high antigen dose therapy of auto-immune encephalomyelitis. Science 263:1139-1143.
96. Howell, M. D., S. T. Winters, T. Olee, et al. 1989. Vaccination against experimental allergic encephalomyelitis with T-cell receptor peptides. Science 246:668-670.
97. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental allergic encephalomyelitis. Nature 341:541-544.
98. Kumar, V., R. Tabibiazar, H. M. Geysen, et al. 1995. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941-1950.
99. Stevens, D. B., W. J. Karpus, K. E. Gould, et al. 1992. Studies of V beta 8 T-cell receptor peptide treatment in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 37:123-129.
100. Matsumoto, Y., M. Tsuchida, H. Hanawa, et al. 1994. T-cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination. Cell. Immunol. 153:468-478.
101. + lymphocytes lack direct immunoregulatory activity. J. Neuroimmunol. 45:15-22.
102. Offner, H., M. Vainiene, B. Celnik, et al. 1994. Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis. J. Immunol. 153:4988-4996.
103. Desquenne-Clark, L., T. R. Esch, L. Otvos, Jr., et al. 1991. T-cell receptor peptide immunization leads to enhanced experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:7219-7223.
104. Vandenbark, A. A., Y. K Chou, D. N. Bourdette, et al. 1992. T-cell receptor peptide therapy for autoimmune disease. J. Autoimmun. 5(Suppl. A):83-92.
105. Zhang, J., R. Medaer, P. Stinissen, et al. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T-cell vaccination. Science 261:1451-1454.
106. Bourdette, D. N., R. H. Whitham, Y. K. Chou, et al. 1994. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and β6.1 CDR2 peptides. J. Immunol. 152:2510-2519.
107. Urban, J. L., V. Kumar, D. H. Komo, et al. 1988. Restricted use of T-cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
108. Utz, U., W. E. Biddison, H. F. McFarland, et al. 1993. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364:243-247.
109. Kotzin, B. L., S. Karuturi, Y. K. Chou, et al. 1991. Preferential T-cell receptor Vβ gene usage in myelin basic protein reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 88:9161-9165.
110. Ben-Nun, A., R. L. Liblau, L. Cohen, et al. 1991. Restricted T-cell receptor Vβ usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary individuals. Proc. Natl. Acad. Sci. USA 88:2466-2470.
111. Wucherpfenning, K. W., K. Ota, K. Endo, et al. 1990. Shared human T-cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248:1016-1029.
112. + cytotoxic T-cell specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359-1366.
113. Mosmann, T. R., H. Cherwinski, M. Bond, et al. 1986. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
114. Swain, S. L., L. M. Bradley, M. Croft, et al. 1991. Helper T-cell subsets: phenotype, function, and the role of lymphokines in regulating their development. Immunol. Rev. 123:115-144.
115. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-250.
116. Ando, D. G., J. Clayton, D. Kono, et al. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 124:132-143.
117. Beraud, E., C. Balzano, A. J. Zamora, et al. 1993. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. J. Neuroimmunol. 47:41-54.
118. Baron, J. L., J. A. Madri, and N. H. Ruddle. 1993. Surface expression of a 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
119. Van der Veen, R. C., and S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213-220.
120. Traugott, U., and P. Lebon. 1988. Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann. Neurol. 24:243-251.
121. Panitch, H. S., R. L. Hirsch, J. Schindler, et al. 1987. Treatment of multiple sclerosis with gamma interferon, exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
122. Cua, D. J., D. R. Hinton, and S. A. Stohlman. 1995. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155:4052-4059.
123. + suppresser cells of autoimmune encephalomyelitis respond to TCR-associated determinants on effector cells by IL-4 secretion. Eur. J. Immunol. 22:1757-1763.
124. Mustafa, M. I., P. Diener, B. Hojeberg, et al. 1991. T-cell immunity and interferon secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31:165-177.
125. Voskuhl, R. R., R. Martin, C. Bergman, et al. 1993. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137-143.
126. Kardys, E., and G. A. Hashim. 1981. Experimental allergic encephalomyelitis in Lewis rats: immunoregulation of disease by a single amino acid substitution in the disease-inducing determinant. J. Immunol. 127:862-866.
127. Saki, K., S. S. Zamvil, D. Mitchell, et al. 1989. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA 86:9470-9474.
128. Wraith, D. C., D. E. Smilek, D. J. Mitchell, et al. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247-255.
129. Smilek, D. E., D. Wraith, S. Hodgkinson, et al. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:9633-9637.
130. The IFNB Multiple Sclerosis Study Group. 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661.
131. Powell, M. B., D. Mitchell, J. Lederman, et al. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J. Immunol. 137:3428-3435.
132. + T cells in murine experimental allergic encephalomyelitis. Science 256:1231-1235.
133. Koh, D. R., W. P. Fung-Leung, A. Ho, et al. 1992. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256:1210-1213.
134. Welsh, J., B. Sapatino, B. Rosenbaum, et al. 1993. Correlation between susceptibility to demyelination and interferon-γ induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells. J. Neuroimmunol. 48:91-98.
135. Wong, G. H. W., J. Clark-Lewis, A. W. Harris, et al. 1984. Effect of cloned interferon-gamma on expression of H-2 and Ia antigen on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur. J. Immunol. 14:52-56.
136. Selmaj, K., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
137. Zajicek, J. P., M. Wing, N. J. Scolding, et al. 1992. Interactions between oligodendrocytes and microglia: a major role for complement and tumor necrosis factor in oligodendrocyte adherence and killing. Brain 115:1611-1631.
138. Lehmann, P. V., T. Forsthuber, A. Miller, et al. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157.
139. Perry, L. L., and M. E. Barzaga. 1987. Kinetics and specificity of B- and T-cell responses in relapsing experimental allergic encephalomyelitis. J. Immunol. 138:1434-1441.
140. McCarron, R. M., R. J. Fallisand, and D. E. McFarlin. 1990. Alterations in T-cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73-79.
141. Perry, L. L., E. Barzaga-Gilbert, and J. L. Trotter. 1991. T-cell sensitization to proteolipid protein in myelin basic protein-induced experimental allergic encephalomyelitis. J. Neuroimmunol. 33:7-15.
142. Cross, A. H., V. K. Tuohy, and C. S. Raine. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261-269.
143. Miller, S. D., B. L. McRae, C. L. Vanderlugt, et al. 1995. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144:225-244.
144. Tan, L. J., M. K. Kennedy, M. C. Dal Canto, et al. 1991. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigenspecific tolerance induction. J. Immunol. 147:1797-1802.
145. McRae, B. L., C. Vanderlugt, M. C. Dal Canto, et al. 1995. Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med. 182:75-85.
146. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, et al. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal energy. J. Immunol. 147:2155-2163.
147. Weiner, H. L., A. Miller, S. J. Khoury, et al. 1995. Treatment of autoimmune disease by oral tolerance to autoantigens. Adv. Exp. Med. Biol. 371B:1217-1223.
148. Miller, A., O. Lider, A. B. Roberts, et al. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune response by the release of TGF-β following antigen specific triggering. Proc. Natl. Acad. Sci. USA 89:421-425.
149. Weiner, H. L., G. A. Mackin, M. Matsui, et al. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321-1324.
150. Cross, A. H., B. Cannella, C. F. Brosnan, et al. 1990. Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:162-170.
151. Skundric, D. S., C. Kim, H. Y. Tse, et al. 1993. Homing to T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice. J. Neuroimmunol. 46:113-121.
152. Owens, T., and S. Sriram. 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13:51-67.
153. Kuchroo, V. K., C. A. Martin, J. M. Greer, et al. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T-cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371-4382.
154. Yednock, T. A., C. Cannon, L. C. Fritz, et al. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356:63-66.
155. Archelos, J. J., S. Jung, M. Maurer, et al. 1993. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:145-154.
156. Poser, C. M. 1995. Notes on the epidemiology of multiple sclerosis. J. Formosan Med. Assoc. 94:300-308.
157. Goverman, J., A. Woods, L. Larson, et al. 1993. Transgenic mice that express a myelin basic protein-specific T-cell receptor develop spontaneous autoimmunity. Cell 72:551-560.
158. Lafaille, J. J., K. Nagashima, M. Katsuki, et al. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399-408.
159. Brabb, T., A. W. Goldrath, P. van Dassow, et al. Triggers of autoimmune disease in a murine T-cell receptor transgenic model for multiple sclerosis. (In preparation.)
160. Amor, S., D. Baker, N. Groome, et al. 1993. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and non-obese diabetic mice. J. Immunol. 150:5666-5672.
161. Tuohy, V. K., R. A. Sobel, Z. Lu, et al. 1992. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39:67-74.
162. Endoh, M., T. Kunishita, J. Neihei, et al. 1990. Susceptibility to proteolipid apoprotein and its encephalitogenic determinants in mice. Int. Arch. Allergy Appl. Immunol. 92:433-441.
163. Yamamura, T., T. Namikawa, M. Endoh, et al. 1986. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J. Neuroimmunol. 12:143-153.
164. Stepaniak, J. A., K. E. Gould, D. Sun, et al. 1995. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J. Immunol. 155:2762-2769.
165. Vukmanovi'c, S., M. Mostarica-Stojkovi'c, I. Zalud, et al. 1990. Analysis of T cell subsets after induction of experimental autoimmune encephalomyelitis in susceptible and resistant strains of rats. J. Neuroimmunol. 27:63-69.
166. Jones, R. E., D. Bourdette, H. Offner, et al. 1992. The synthetic 87-99 peptide of myelin basic protein is encephalitogenic in buffalo rats. J. Neuroimmunol. 37:203-212.
167. Jones, R. E., D. N. Bourdette, H. Offner, et al. 1990. Myelin basic protein-specific T cells induce demyelinating experimental autoimmune encephalomyelitis in buffalo rats. J. Neuroimmunol. 30:61-69.